BRAF and Langerhans cell histiocytosis: Moreover, with an understanding of the pathogenesis of LCH, patients with BRAF-V600E and MAPK pathway (RAS-RAF-MEK-ERK) mutations accounted for a large proportion of LCH (18–20).